There has been very little progress in treating or preventing antipsychotic-induced tardive dyskinesia

被引：1
|
作者：
van Harten, Peter [1 ]
机构：
[1] Maastricht Univ, Sch Mental Hlth & Neurosci, Div Neurosci, NL-6229 ER Maastricht, Netherlands
来源：
EVIDENCE-BASED MENTAL HEALTH | 2018年 / 21卷 / 03期
关键词：
D O I：
10.1136/ebmental-2018-300006
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：E10 / +
页数：2
相关论文
共 50 条
  • [41] Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials
    Lockwood, Jonathan Tomas
    Remington, Gary
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) : 407 - 421
  • [42] Thalamotomy for severe antipsychotic induced tardive dyskinesia and dystonia
    Hillier, CEM
    Wiles, CM
    Simpson, BA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02): : 250 - 251
  • [43] Antipsychotic-induced life-threatening 'esophageal dyskinesia'
    Horiguchi, J
    Shingu, T
    Hayashi, T
    Kagaya, A
    Yamawaki, S
    Horikawa, Y
    Kitadai, Y
    Inoue, M
    Nishikawa, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) : 123 - 127
  • [44] A case report of reemergence of antipsychotic-induced dyskinesia with citalopram
    Duggal, Harpreet S.
    Mendhekar, Dattatreya N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 803 - 803
  • [45] Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis
    Bakker, PR
    van Harten, PN
    van Os, J
    SCHIZOPHRENIA RESEARCH, 2006, 83 (2-3) : 185 - 192
  • [46] BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis
    Miura, Itaru
    Zhang, Jian-Ping
    Nitta, Masahiro
    Lencz, Todd
    Kane, John M.
    Malhotra, Anil K.
    Yabe, Hirooki
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2014, 152 (2-3) : 365 - 372
  • [47] Pharmacogenetics of antipsychotic induced weight gain and tardive dyskinesia.
    Basile, VS
    Masellis, M
    Ozdemir, V
    Walker, ML
    Meltzer, HY
    Lieberman, JA
    Potkin, SG
    Alva, G
    Kennedy, JL
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 467 - 467
  • [48] CLINICAL DIFFERENCES BETWEEN METOCLOPRAMIDE-INDUCED AND ANTIPSYCHOTIC-INDUCED TARDIVE DYSKINESIAS
    LANG, AE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (02) : 137 - 139
  • [49] Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions
    Demler, Tammie Lee
    Krieger, Kelly
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (01) : 12 - 17
  • [50] Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies
    Lister, Josh
    Nobrega, Jose N.
    Fletcher, Paul J.
    Remington, Gary
    PSYCHOPHARMACOLOGY, 2014, 231 (11) : 2237 - 2249
12345